공고 • Jul 21
Siegfried Holding AG to Report Fiscal Year 2026 Results on Feb 19, 2027 Siegfried Holding AG announced that they will report fiscal year 2026 results on Feb 19, 2027 공고 • Jul 17
Siegfried Holding Ag Announces Appointment of Eduardo Montanha as Chief Operating Officer and Member of the Executive Committee, Effective September 1, 2026 Siegfried Holding AG announced that Eduardo Montanha was appointed as Chief Operating Officer and member of the Executive Committee, effective September 1, 2026. The appointment followed Siegfried's previously announced decision to combine the Chief Operating Officer roles for Drug Substances and Drug Products into one position. Eduardo Montanha brought more than 20 years of international leadership experience in pharmaceutical and biopharmaceutical manufacturing. Most recently, he served as Executive Vice President, Head of Global Technical Operations & Quality at Fresenius Kabi, where he led an integrated global network of around 30 manufacturing sites across multiple regions. Earlier in his career, he held senior leadership positions at Takeda, Sandoz, Hexal, and Hoechst/Aventis, covering technical operations, quality, supply, and large-scale manufacturing networks. Eduardo Montanha held a bachelor's degree in chemical engineering, a postgraduate qualification in Industrial Automation, and an MBA in Project Management. He brought extensive international leadership experience, having lived and worked across Europe and Latin America. 공고 • Mar 27
Siegfried Holding AG, Annual General Meeting, Apr 14, 2026 Siegfried Holding AG, Annual General Meeting, Apr 14, 2026, at 10:00 W. Europe Standard Time. 공고 • Feb 21
Siegfried Announces Management Changes Siegfried will consolidate the Chief Operating Officer roles currently split between Drug Substances and Drug Products into one position. In this context, Henrik Krüpper will be stepping down from his responsibilities as Chief Operating Officer Drug Substances to pursue opportunities outside the company, effective March 1, 2026. Stefan Randl has been appointed ad interim Chief Operating Officer Drug Substances in addition to his role as Chief Scientific Officer until a Chief Operating Officer is appointed. 공고 • Feb 09
Siegfried Holding AG to Report First Half, 2026 Results on Aug 21, 2026 Siegfried Holding AG announced that they will report first half, 2026 results on Aug 21, 2026 공고 • Sep 04
Siegfried Holding AG to Report Fiscal Year 2025 Results on Feb 20, 2026 Siegfried Holding AG announced that they will report fiscal year 2025 results on Feb 20, 2026 공고 • Mar 24
Siegfried Holding AG, Annual General Meeting, Apr 10, 2025 Siegfried Holding AG, Annual General Meeting, Apr 10, 2025, at 10:00 W. Europe Standard Time. 공고 • Jan 30
Siegfried Holding AG to Report First Half, 2025 Results on Aug 21, 2025 Siegfried Holding AG announced that they will report first half, 2025 results on Aug 21, 2025 공고 • Aug 22
Siegfried Holding AG to Report Fiscal Year 2024 Results on Feb 18, 2025 Siegfried Holding AG announced that they will report fiscal year 2024 results on Feb 18, 2025 공고 • Aug 20
Siegfried Holding AG to Report First Half, 2024 Results on Aug 22, 2024 Siegfried Holding AG announced that they will report first half, 2024 results on Aug 22, 2024 공고 • Jul 02
Siegfried Holding AG (SWX:SFZN) completed the acquisition of early-phase CDMO site in Grafton, Wisconsin from Curia Global, Inc. Siegfried Holding AG (SWX:SFZN) agreed to acquire early-phase CDMO site in Grafton, Wisconsin from Curia Global, Inc. on June 12, 2024. The acquisition is financed from existing funds. the transaction is subject to customary closing conditions and is expected to close by July 1, 2024.Siegfried Holding AG (SWX:SFZN) completed the acquisition of early-phase CDMO site in Grafton, Wisconsin from Curia Global, Inc on july 1, 2024. As part of the acquisition, all projects at the Grafton site have been transferred to Siegfried and the Siegfried Acceleration Hub will continue to fulfill all commitments to its existing customers. 공고 • May 18
Siegfried Announces Executive Changes Siegfried announces two changes to its Executive Committee: Irene Wosgien, currently serving as Chief Operating Officer Drug Substances (COO DS), will take over the global responsibility as Chief Human Resources Officer (CHRO) from Arnoud Middel who will leave Siegfried end of June 2023. Henrik Krupper, currently CEO of HCS Group, will join Siegfried to become the new COO DS. Irene Wosgien will take over as CHRO on 1 July 2023 while Arnoud Middel will assist her during the transition and will continue to support key HR projects until the end of the year. Henrik Krupper will assume his role on 1 November 2023 at the latest. Until then and starting on 1 July 2023, Marcel Imwinkelried will lead the DS technical operations organization in parallel to his regular role as Chief Operating Officer Drug Products. Both, Irene Wosgien and Henrik Krupper, will serve as members of Siegfried's Executive Committee. Arnoud Middel joined Siegfried in 2011 and since then has successfully built a professional global HR function which has been instrumental to Siegfried's organizational development and strong growth over the years. After 12 years with the company, he decided to leave Siegfried in order to pursue private ventures and prepare them next chapters of his career. Henrik Krupper (52, German citizen) holds a diploma (Dipl.-Ing.) in mechanical engineering with a specialization in process engineering from the Technical University (RWTH) Aachen (Germany). After completing his studies, he started his career at Th. Goldschmidt AG as site excellence and production manager followed by positions with increasing operational and managerial responsibilities at Evonik Industries AG (formerly Degussa AG), City Solar AG, Q-Cells SE and Soltecture GmbH. In 2012, he joined HCS Group, an international specialty chemicals company based in Germany, as Managing Director and Chief Commercial Officer and was appointed to his current role of Chief Executive Officer of the company in 2019. 공고 • May 06
Siegfried Holding AG (SWX:SFZN) acquired 95% stake in DiNAMIQS from DiNAQOR AG. Siegfried Holding AG (SWX:SFZN) acquired 95% stake in DiNAMIQS from DiNAQOR AG on May 4, 2023.Siegfried Holding AG (SWX:SFZN) completed the acquisition of 95% stake in DiNAMIQS from DiNAQOR AG on May 4, 2023. 공고 • Aug 20
Siegfried Holding AG to Report Fiscal Year 2022 Results on Feb 22, 2023 Siegfried Holding AG announced that they will report fiscal year 2022 results on Feb 22, 2023